Silva Francisco 4
4 · BioRestorative Therapies, Inc. · Filed Aug 31, 2023
Insider Transaction Report
Form 4
Silva Francisco
VP of Research and Development
Transactions
- Purchase
Common Stock
2023-08-31$2.22/sh+4,954$10,998→ 164,644 total
Holdings
- 12,136(indirect: By IRA)
Common Stock
- 9
Stock Option
Exercise: $3000.00Exp: 2024-10-23→ Common Stock (9 underlying) - 6
Stock Option
Exercise: $3000.00Exp: 2025-09-04→ Common Stock (6 underlying) - 3
Stock Option
Exercise: $3000.00Exp: 2024-02-18→ Common Stock (3 underlying) - 1
Stock Option
Exercise: $3000.00From: 2014-03-12Exp: 2024-03-11→ Common Stock (1 underlying) - 15
Stock Option
Exercise: $3000.00Exp: 2026-06-10→ Common Stock (15 underlying) - 1
Stock Option
Exercise: $3000.00Exp: 2023-10-04→ Common Stock (1 underlying) - 20
Stock Option
Exercise: $3000.00Exp: 2027-07-12→ Common Stock (20 underlying) - 293,479
Stock Option
Exercise: $5.08Exp: 2031-03-18→ Common Stock (293,479 underlying) - 42,059
Stock Option
Exercise: $5.08Exp: 2031-11-04→ Common Stock (42,059 underlying) - 106,762
Stock Option
Exercise: $2.91Exp: 2033-02-17→ Common Stock (106,762 underlying) - 25
Stock Option
Exercise: $3000.00Exp: 2028-10-29→ Common Stock (25 underlying)
Footnotes (5)
- [F1]Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024.
- [F2]The option is currently exercisable.
- [F3]The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
- [F4]The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
- [F5]The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.